APA

Poddubnaya I. V., Alekseev S. M., Kaplanov K. D., Lukavetskyy L. M., Rekhtman G. B., Dolai T. K., Attili V. S. S., Bermúdez C. D., Isaev A. A., Chernyaeva E. V. & Ivanov R. A. (20200214). Proposed rituximab biosimilar BCD-020 versus reference rituximab for treatment of patients with indolent non-Hodgkin lymphomas: An international multicenter randomized trial. : Hematological oncology.

Chicago

Poddubnaya Irina V, Alekseev Sergey M, Kaplanov Kamil D, Lukavetskyy Les M, Rekhtman Grigoriy B, Dolai Tuphan K, Attili V Satya Suresh, Bermúdez Carlos D, Isaev Aleksandr A, Chernyaeva Ekaterina V and Ivanov Roman A. 20200214. Proposed rituximab biosimilar BCD-020 versus reference rituximab for treatment of patients with indolent non-Hodgkin lymphomas: An international multicenter randomized trial. : Hematological oncology.

Harvard

Poddubnaya I. V., Alekseev S. M., Kaplanov K. D., Lukavetskyy L. M., Rekhtman G. B., Dolai T. K., Attili V. S. S., Bermúdez C. D., Isaev A. A., Chernyaeva E. V. and Ivanov R. A. (20200214). Proposed rituximab biosimilar BCD-020 versus reference rituximab for treatment of patients with indolent non-Hodgkin lymphomas: An international multicenter randomized trial. : Hematological oncology.

MLA

Poddubnaya Irina V, Alekseev Sergey M, Kaplanov Kamil D, Lukavetskyy Les M, Rekhtman Grigoriy B, Dolai Tuphan K, Attili V Satya Suresh, Bermúdez Carlos D, Isaev Aleksandr A, Chernyaeva Ekaterina V and Ivanov Roman A. Proposed rituximab biosimilar BCD-020 versus reference rituximab for treatment of patients with indolent non-Hodgkin lymphomas: An international multicenter randomized trial. : Hematological oncology. 20200214.